Concepedia

Sapir Dreyer-Alster

SD

Statistics

Publications

10

Citations

883

H-Index

10

Active since

2021

Affiliations

Sheba Medical Center(Current)

Tel Aviv University

Sapir Dreyer-Alster is an author at Sheba Medical Center specializing in multiple sclerosis, immunology, and immunization.

ORCID

Publications per year

2021–2023

10

Publications

10

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster et al. · Therapeutic Advances in Neurological Disorders · 2021 · 362 citations · Full text

, , +17

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Anat Achiron, Mark Dolev, Shay Menascu et al. · Multiple Sclerosis Journal · 2021 · 224 citations · Full text

, , +10

Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study

Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster et al. · Journal of Neuroimmunology · 2021 · 79 citations · Full text

, , +14

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose

Sapir Dreyer-Alster, Shay Menascu, Mathilda Mandel et al. · Journal of the Neurological Sciences · 2022 · 64 citations · Full text

, , +12

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod

Anat Achiron, Mathilda Mandel, Michael Gurevich et al. · Journal of Neurology · 2022 · 45 citations · Full text

, , +14

1–5 of 10